Skip to Content
Merck
CN

Protein O-GlcNAcylation and cardiovascular (patho)physiology.

The Journal of biological chemistry (2014-10-23)
Susan A Marsh, Helen E Collins, John C Chatham
ABSTRACT

Our understanding of the role of protein O-GlcNAcylation in the regulation of the cardiovascular system has increased rapidly in recent years. Studies have linked increased O-GlcNAc levels to glucose toxicity and diabetic complications; conversely, acute activation of O-GlcNAcylation has been shown to be cardioprotective. However, it is also increasingly evident that O-GlcNAc turnover plays a central role in the delicate regulation of the cardiovascular system. Therefore, the goals of this minireview are to summarize our current understanding of how changes in O-GlcNAcylation influence cardiovascular pathophysiology and to highlight the evidence that O-GlcNAc cycling is critical for normal function of the cardiovascular system.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
N-Acetyl-D-glucosamine, ≥95% (HPLC)
Sigma-Aldrich
N-Acetyl-D-glucosamine, suitable for cell culture, BioReagent
Sigma-Aldrich
N-Acetyl-D-glucosamine, ≥99% (HPLC)
Supelco
N-Acetylglucosamine, Pharmaceutical Secondary Standard; Certified Reference Material